SFX by Ex Libris Inc.

Title:	Dissociation of gp120 from HIV-1 virions induced by soluble CD4
Source:	Science [0036-8075] Moore, J P yr:1990

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	MUKOYAMA, A. "INHIBITION OF ROTAVIRUS AND ENTEROVIRUS INFECTIONS BY TEA EXTRACTS." Japanese journal of medical science & biology 44.4 (1991): 181-186.
description	2.	Moore, J.P., J P. "Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbentassay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4." AIDS 4.4 (1990): 297-305.
description	3.	Moore, J P P. "Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates." Journal of virology 66.1 (1991): 235-43.
description	4.	Fransen, K. "Evaluation of four HIV antigen tests." Journal of Virological Methods 93.1-2 (2001): 189-193.
description	5.	Sattentau, Q J J. "Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes." The Journal of experimental medicine 170.4 (1989): 1319-34.
description	6.	Nakayama, M. "Inhibition of the infectivity of influenza virus by tea polyphenols." Antiviral research 21.4 (1993): 289-99.
description	7.	Hoffman, T L L. "A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 Env to chemokine receptors." Proceedings of the National Academy of Sciences of the United States of America 97.21 (2000): 11215-11220.
description	8.	Orloff, S L L. "Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4." Journal of virology 67.3 (1993): 1461-71.
description	9.	Ho, David D D. "HIV-1 at 25." Cell 133.4 (2008): 561-5.
description	10.	ARTHOS, J. "IDENTIFICATION OF THE RESIDUES IN HUMAN CD4 CRITICAL FOR THE BINDING OF HIV." Cell 57.3 (1989): 469-481.
description	11.	Forsman, A. "Why is HIV a pathogen?" Trends in Microbiology 16.12 (2008): 555-560.
description	12.	Utsumi, K. "Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug." Acta medica Okayama (1983): 385-391.
description	13.	Gilchrist, A. "Evaluation of chemokine receptor CCR1 antagonists using a beta-arrestin translocation assay." The Journal of clinical pharmacology 2011. 1339-1340.
description	14.	Hoebeke, J. "Analysis of human CD4-antibody interaction using the BIAcore system." Journal of immunological methods 183.1 (1995): 141-148.
description	15.	Mortuza, Gulnahar B B. "High-resolution structure of a retroviral capsid hexameric amino-terminal domain." Nature 431.7007 (2004): 481-5.
description	16.	Saladino, R. "Advances and challenges in the synthesis of highly oxidized natural phenols with antiviral, antioxidant and cytotoxic activities." Current medicinal chemistry 15.15 (2008): 1500-19.
description	17.	SMITH, D H H. "BLOCKING OF HIV-1 INFECTIVITY BY A SOLUBLE, SECRETED FORM OF THE CD4 ANTIGEN." Science 238.4834 (1987): 1704-1707.
description	18.	Ulm, J Wesley W. "Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction." Virology 363.2 (2007): 245-55.
description	19.	Minunni, M. "Development of biosensors with aptamers as bio-recognition element: the case of HIV-1 Tat protein." Biosensors & bioelectronics 20.6: 1149-1156.
description	20.	Glebe, D. "Role of glycosaminoglycans for binding and infection of hepatitis B virus." Cellular microbiology 10.1 (2007): 122-33.